Anti-PD-1 With or Without Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer

被引：0

作者：

Teng, F. ^{[1
]}

Wang, P. ^{[2
,3
]}

机构：

[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China

[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China

[3] Shandong Univ, Shandong Canc Hosp & Inst, Cheeloo Coll Med, Jinan, Peoples R China

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2943

引用

页码：E455 / E456

页数：2

共 50 条

[41] Inflammatory soluble factors as potential biomarkers in non-small cell lung cancer treated with anti-PD-1 inhibitors
Sasada, Tetsuro
Matsuo, Norikazu
Ohtake, Junya
Azuma, Koichi
CANCER SCIENCE, 2018, 109 : 1327 - 1327
[42] Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer
Rogado, Jacobo
Pozo, Fernando
Troule, Kevin
Sanchez-Torres, Jose Miguel
Romero-Laorden, Nuria
Mondejar, Rebeca
Donnay, Olga
Ballesteros, Anabel
Pacheco-Barcia, Vilma
Aspa, Javier
Al-Shahrour, Fatima
Alfranca, Arantzazu
Colomer, Ramon
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (11): : 2241 - 2249
[43] Effect of anti-PD-1 therapy on immune cells in the peripheral blood of non-small cell lung cancer patients
Vetsika, Eleni-Kyriaki
Kallergi, Galatea
Aggouraki, Despoina
Lyristi, Zaharoula
Koukos, Aristeidis
Kourougkiaouri, Despoina
Koinis, Filippos
Georgoulias, Vassilis
Kotsakis, Athanasios
CANCER RESEARCH, 2017, 77
[44] Immunologic monitoring markers of clinical responses to anti-PD-1 therapy for non-small cell lung cancer.
Oka, Mikio
Kurose, Koji
Ohue, Yoshihiro
Karasaki, Takahiro
Futami, Junichiro
Masuda, Takeshi
Fukuda, Masaaki
Kinoshita, Akitoshi
Shimizu, Katsuhiko
Nakata, Masao
Hattori, Noboru
Yamaguchi, Hiroyuki
Fukuda, Minoru
Oga, Toru
Kakimi, Kazuhiro
CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 104 - 105
[45] The expression of aryl hydrocarbon receptor predicts responses to anti-PD-1 antibodies in non-small cell lung cancer
Han, Si-Chong
Yang, Yaning
Wang, Gui-Zhen
Fang, Wenfeng
Zhang, Li
Wang, Yan
Zhou, Guang-Biao
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[46] Pseudoprogression presenting as intestinal perforation in non-small cell lung cancer treated with anti-PD-1: A case report
Kim, Hee Kyung
Baek, Seung-Woo
Jeong, Yusook
Yang, Yaewon
Kwon, Jihyun
Han, Hye Sook
An, Jin-Young
Woo, Chang Gok
Lee, Ok-Jun
Lee, Taek Gu
Lee, Ki Hyeong
MOLECULAR AND CLINICAL ONCOLOGY, 2019, 11 (02) : 132 - 134
[47] Serum biomarkers during the first cycle of anti-PD-1 antibody therapies in non-small cell lung cancer
Ota, T.
Takeda, T.
Fukui, T.
Nakahara, Y.
Kudo, K.
Okabe, T.
Hayashi, H.
Otani, S.
Hiyoshi, Y.
Yonesaka, K.
Sugiura, T.
Suzumura, T.
Terashima, M.
Nakano, Y.
Hasegawa, Y.
Tsukuda, H.
Matsui, K.
Masuda, N.
Fukuoka, M.
ANNALS OF ONCOLOGY, 2018, 29
[48] Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer
Shibaki, Ryota
Murakami, Shuji
Shinno, Yuki
Matsumoto, Yuji
Goto, Yasushi
Kanda, Shintaro
Horinouchi, Hidehito
Fujiwara, Yutaka
Motoi, Noriko
Yamamoto, Noboru
Ohe, Yuichiro
THORACIC CANCER, 2019, 10 (04) : 815 - 822
[49] Anti-PD-1 antibodies in non-small cell lung cancer (NSCLC): The real-life setting experience
Dudnik, E.
Moskovitz, M.
Wollner, M.
Zer, A.
Bar, J.
Agbarya, A.
Idan, T.
Shechtman, Y.
Abu Amna, M.
Peled, N.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S136 - S136
[50] DNA methylation profiles associated with response to anti-PD-1 immunotherapy in non-small cell lung cancer.
Cho, Jae-Won
Hong, Min Hee
Ha, Sang-Jun
Kim, Young-Joon
Lee, Insuk
Kim, Hye Ryun
CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 33 - 33

← 1 2 3 4 5 →